[
 {
  "document": {
   "authors": "Priya S",
   "contact_info": "priya@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "32187464.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "CHEBI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MESH",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Timeline",
     "type": "LIST",
     "value": null,
     "value_list": [
      "15 days",
      "28 days"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Research"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Published"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Results"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "PubMed",
       "title": "N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMoa2001282.",
       "ref": "32187464",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Research"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Published"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Results"
       ]
      }
     },
     {
      "evidence": "In the modified intention to-treat population, the median time to clinical improvement was 15 days in the lopinavir\u2013ritonavir group, as compared with 16 days in the\nstandard-care group (hazard ratio, 1.39; 95% CI, 1.00 to 1.91) (Table S1 and Fig. S1 in the Supplementary Appendix)."
     },
     {
      "set": {
       "Timeline": [
        "15 days"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Timeline"
      ]
     },
     {
      "evidence": "The 28-day mortality was numerically lower in the lopinavir\u2013ritonavir group than in the standardcare group for either the intention-to-treat population\n(19.2% vs. 25.0%; difference, \u22125.8 percentage points; 95% CI, \u221217.3 to 5.7)."
     },
     {
      "set": {
       "Timeline": [
        "28 days"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Mortality"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Timeline"
      ]
     },
     {
      "evidence": "Gastrointestinal adverse events including nausea, vomiting, and diarrhea were more common in lopinavir\u2013ritonavir group than in the standard-care group (Table 4)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Nausea"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Vomiting"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Diarrhea"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "PublicationType"
      ]
     },
     {
      "unset": [
       "PublicationStatus"
      ]
     },
     {
      "unset": [
       "Section"
      ]
     }
    ]
   }
  ]
 }
]